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Tokyo, JapanA B S T R A C TBackground: There are currently large regional variations in the
frequency of physician-patient encounters for the treatment of chronic
lifestyle diseases in Japan. These variations may be inﬂuenced by
competition among physicians, and supplier-induced demand (SID) in
health care can occur when physicians manipulate their patients’
demand for medical services to increase the use of health care.
Objectives: To analyze patient data to investigate the presence of SID
in the treatment of chronic diseases at the regional level in Japan.
Methods: We tested the hypothesis that clinic and hospital physicians
in areas of high competition (high physician density) are more likely to
recommend a sooner follow-up consultation than do those in areas of
lower competition (lower physician density). Using random-effects
multilevel models, we analyzed patient survey data and administrative
claims data to estimate the effects of physician density on encounter
frequency and medical charges. In the analysis of claims data, we usedee front matter Copyright & 2015, International S
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.1016/j.vhri.2015.03.010
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13-0033, Japan.the mean drug administration period as a proxy for the frequency of
physician-initiated encounters. Results: Our analysis showed that
encounter frequency was signiﬁcantly associated with clinic physician
density, but there were no consistent associations with hospital
physician density. Increases in physician density were signiﬁcantly
associated with increases in both clinic and hospital medical charges,
and these associations were independent from encounter frequency.
Conclusions: The results of our study indicate the presence of SID in
Japan. Further studies should investigate whether more frequent
physician-patient encounters provide clinical advantages to patients.
Keywords: competition, diabetes, hypertension, multilevel modeling,
ofﬁce visits, primary health care.
Copyright & 2015, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
In Japan’s unique health care system, primary care can be provided
by physicians in both clinics and hospitals. Most of the clinic-based
physicians have experience working at hospitals in various clinical
disciplines [1]. After several years of practice at hospitals, these
physicians proceed to open their own clinic, usually as a solo
practitioner, without any formal training in primary care. Because
Japan has no nationally accredited training program in any medical
and surgical specialty, physicians are free to open their own clinics
in any discipline of their choice [2]. In comparison to the over-
whelming number of specialized clinic physicians, there are rela-
tively few physicians who have had formal training in primary care.
Many patients with lifestyle diseases are therefore treated by
specialists in hospitals, such as diabetes specialists and cardiologists.
Japanese patients are free to seek care at any medical
institution irrespective of location or insurer. Furthermore,medical fees are largely ﬁxed, regardless of the skills and
expertise of the attending physician. Some patients may hold
assumptions that hospitals provide higher quality of care than do
clinics, and prefer to be treated at hospitals even if their
conditions are treatable at clinics. Many clinics have therefore
equipped themselves with various advanced medical devices to
attract patients and maintain a competitive edge with hospitals.
The number of physician visits in Japan is extremely high
compared with other developed countries. The average number
of physician consultations per capita in Japan in 2009 was 13.2,
whereas the Organisation for Economic Co-operation and Devel-
opment average was less than half that ﬁgure at 6.5 [3]. Currently,
there are large variations in the frequency of physician-patient
encounters among different regions, as well as between
clinics and hospitals for the treatment of lifestyle diseases in
Japan; the intrinsic variations in patient attributes and disease
distribution have been unable to explain these variations [4].ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
conﬂicts of interest with regard to the content of this article.
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patient encounter frequency may suggest the overuse or underuse
of health care.
In the health care setting, supplier-induced demand (SID) refers
to the concept where physicians manipulate their patients’
demand for medical services to increase the utilization of health
care [5]. Because patients do not have sufﬁcient expertise to judge
the necessity and quality of the services provided, physicians
have considerable inﬂuence on the type and quantity of these
services. Physicians, however, should ideally supply services on
the basis of each patient’s medical need, and the provision of
health care should not be driven by their private economic
interests [6].
Many studies have been conducted to test the existence and
extent of SID in health care. The most commonly used approach
in these studies is the use of physician/population ratios, or
physician density. These studies have examined the changes to
the utilization or price of medical services in response to changes
in the number of physicians in a speciﬁed region [7,8]. An
Australian study found that a 10% increase in the supply of
general practitioners (GPs) was associated with an increase of
between 4.6% and 5.1% in provided services [9]. Wilensky and
Rossiter [10] reported that physician densities were signiﬁcantly
correlated with increased physician-initiated consultations and
higher price of care. In contrast, a study on SID in primary care
physician services in Norway reported that physicians did not
increase their output in response to increased physician density
[6]. Scott and Shiell [11] found that GPs in areas of high competi-
tion (areas with high GP/population ratios) were more likely to
recommend a follow-up consultation than were GPs in areas of
lower competition.
Studies in Japan have shown mixed results: some studies
have demonstrated the presence of SID in Japan [12–15],
whereas others have not [16–17]. Most of these previous studies,
however, have used regional aggregated data, and are therefore
susceptible to ecological fallacy. In addition, many of these
studies have failed to control for the risk for health care
utilization in patients. Furthermore, few studies have addressed
differences in medical services utilization between hospitals
and clinics, or have analyzed the association between physician
density and frequency of medical expenditure in Japan. There is
therefore a need to investigate these themes to improve under-
standing of variations in health care utilization and costs.
Lifestyle diseases and their complications are major causes
of morbidity and mortality in Japan, with an estimated 9.5
million patients with diabetes [18] and 43 million patients with
hypertension [19]. Because physician visits are more frequent in
Japan than in other developed countries, there is a need to
carefully evaluate the impact of SID in the treatment of these
diseases.
In this study, we analyzed individual patient data to examine
the possible effects of SID in the treatment of chronic diseases,
with a focus on hypertension and diabetes. Our research
hypothesis is that physician-patient encounter frequency is
inﬂuenced by physician density, as well as by payment systems
for medical services. To test this hypothesis, we used multilevel
models to examine whether a signiﬁcant proportion of the
between-area variation in the utilization of physician services
is attributable to the area-level factor of physician density.
Multilevel modeling is appropriate for data with nested sources
of variability, that is, involving units at a micro level (patients)
nested within those at a macro level (regions) [20]. We also
investigated the inﬂuence of SID on medical charges using a
model that accounts for patient characteristics. Because of
anticipated differences in encounter frequencies between clinics
and hospitals, our analyses were conducted separately for the
two institutional types.Methods
Data Sources and Study Population
We used two data sources for this analysis: the ﬁrst comprised
data from patient surveys conducted by Japan’s Ministry of
Health, Labour, and Welfare in ﬁscal year (FY) 2005 and FY2011,
and the second comprised administrative claims data provided
by the Japan Health Insurance Association.
The Ministry of Health, Labour, and Welfare conducts patient
surveys every 3 years on outpatients who visit randomly sampled
medical institutions. Information collected includes type (hospi-
tal or clinic) and location of the institution (municipality) where
care is obtained, patients’ demographic characteristics, primary
diagnosis (International Classiﬁcation of Diseases 10th Revision
codes), and the time interval from the previous visit to the index
visit. The data include patients of all ages according to the
distribution in Japan, although the data lack information to
identify visits for the treatment of lifestyle diseases from the
others. In this study, we considered encounter interval as a proxy
for encounter frequency. From the survey database, we selected
patients who were at least 20 years old and whose principal
diagnosis was either hypertension (International Classiﬁcation of
Diseases, 10th Revision codes: I10, I11, I12, I13, and I15) or diabetes
(E11, E12, E13, and E14).
Administrative claims data were obtained from a computer-
ized database of medical bills issued by medical institutions to
insurers for the purpose of reimbursement. The Japan Health
Insurance Association primarily provides employees’ health
insurance, and its enrollees are mainly salaried employees of
small and medium businesses. Therefore, most of the enrollees
are younger than 65 years.
For this study, we analyzed claims data from between April
and July 2013. The data included age, sex, diagnoses, medical
charges, prescription records, and type and location of the
medical institutions. The study subjects were patients who were
at least 20 years old, were enrolled in the target health insurance
system between April and July 2013, had a documented diagnosis
of hypertension or diabetes, and were prescribed antihyperten-
sive drugs or diabetes drugs. Patients who were undergoing
hemodialysis, receiving home-based care, or hospitalized during
the study period were excluded from the analysis. Because
Japan’s health care system does not allow reﬁll prescriptions in
the treatment of hypertension and diabetes, the main purpose of
outpatient visits is to obtain regular drug prescriptions. Physi-
cians are therefore able to arbitrarily increase the number of
encounters by shortening each drug administration period. For
this reason, we were able to use the encounter interval (given by
the average drug administration period) as a proxy for the
frequency of physician-initiated visits.
Statistical Analysis
Multilevel models were developed to examine the effects of
physician density on physician-patient encounter frequency. In
the absence of SID, patients’ demographic factors and medical
conditions would be expected to be the primary determinants of
encounter frequency. In addition to these patient-level factors,
we aimed to identify the extent to which area-level determinants
(physician density) would inﬂuence physician-patient encounter
frequency and medical charges.
Patient-Level Variables
The patient-level variables included age and sex in the patient
survey data and age, sex, and number of comorbidities in the
administrative claims data. Patients’ age was stratiﬁed into three
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tion of the Charlson comorbidity index to measure the following
comorbidities in the administrative claims data: acute myocar-
dial infarction, congestive heart failure, peripheral vascular dis-
ease, cerebrovascular disease, dementia, pulmonary disease,
connected tissue disease, peptic ulcer, liver disease, diabetes,
paraplegia, renal failure, malignant tumors, metastatic tumors,
and HIV/AIDS [21,22].
Area-Level Variable
The area-level variable used was physician density (physician/
population ratio) in the medical care district where each subject
medical institution was located. Medical care districts in Japan
are subprefectural regions consisting of several municipalities.
These government-stipulated regions are designed to provide
comprehensive acute care, subacute care, convalescent care, and
long-term care. The characteristics of the medical care districts
analyzed in this study are presented in Table 1. Physician density
was calculated separately for hospital physicians and clinic
physicians using data from a population census and the physi-
cian survey conducted by the Ministry of Health, Labour, and
Welfare.
Multilevel Linear Regression (Mixed-Effects) Model
Our analysis was based on the assumption that encounter
frequency is partly dependent on patient attributes and physician
density. In this study, we used physician-patient encounter
intervals as a proxy of encounter frequency. Multilevel linear
regression models were ﬁtted to the data with individual patients
at the ﬁrst level and regions (medical care district) at the second
level; the dependent variable was encounter intervals. We
assumed that coefﬁcients for patient-level and area-level varia-
bles are ﬁxed and that the intercept is a random variable. TheTable 1 – Characteristics of the medical care districts use
Data No. of samples in
medical care districts
Population
(1000
people)
Hypertension Diabetes
Patient survey data, FY2005
Mean  SD 153.7  128.5 71.5  72 576.8  672.9
Range 1–845 0–536 23.7–5469.4
Percentile
25th 63 25 149.5
50th 124 50 346.5
75th 201 94 797.8
Patient survey data, FY2011
Mean  SD 166.8  134.8 78.0  74.4 372.4  405
Range 4–727 1–498 21.7–2665.3
Percentile
25th 72 28 97.6
50th 134 59 227
75th 212 98 476.6
Administrative claims data, FY2013
Mean  SD 5,985  5,955 2,345  2,431 365.8  398.2
Range 264–46,961 82–19,796 21.7–2665.3
Percentile
25th 2,061 746 97.2
50th 4,295 1,693 223.4
75th 7,758 3,115 473.9
FY, ﬁscal year.multilevel linear model can be expressed with the following
formula:
Yij¼β00þβk0Xkijþβ01Wjþðμ0jþεijÞ
where Yij represents the encounter interval of the ith patient in
the jth region, which is related to the vector of patient-level
explanatory variables X and the vector of area characteristics W
(physician density). The terms m0j and εij represent random
components for area-level effects and patient-level effects,
respectively. m0j is the variance around the grand mean due to
between-area differences, and εij is the variance around the grand
mean due to between-patient differences. These two random
components were assumed to be normally distributed and
uncorrelated. Because large variations were observed in popula-
tion size and patient numbers at the regional level, we randomly
sampled 400 patients with hypertension and 100 patients with
diabetes from each medical care district. For areas that had fewer
than the targeted number of patients for a particular disease, we
used all available subjects for the analysis. These areas, however,
accounted for less than 5% of the sample.
Next, we examined the effects of patient-level and area-level
variables on medical charges using a multilevel linear model that
can be expressed with the following formula:
Costij¼β00þβk0XkijþγZijþβ01Wjþðμ0jþεijÞ
where Costij represents the total (cumulative) medical charges
during the study period, which is related to the vector of patient-
level explanatory variables X, the physician encounter interval Z,
and the vector of municipality characteristics W. The other terms
are the same as in the formula described above.
IBM SPSS Version 20 (SPSS Japan, Inc., Tokyo, Japan) was used
to extract and transform the patient survey data and the claims
data. Stata/SE Version 11 (Stata Corp LP, College Station, TX) was
used in multilevel regression analyses. Intraclass correlation
coefﬁcients were calculated to examine the cluster effects usingd in this study.
No. of physicians
in medical
institutions
per 1000 people
Number of clinic
physicians per
1000 people
No. of hospital
physicians per
1000 people
1.32  0.91 0.83  0.66 0.49  0.29
0.01–11.08 0–8.46 0.01–2.62
0.72 0.41 0.26
1.25 0.73 0.47
1.72 1.07 0.67
1.91  0.86 1.21  0.69 0.70  0.23
0.06–11.81 0.04–8.92 0.02–2.89
1.43 0.83 0.56
1.7 1.02 0.69
2.13 1.35 0.82
1.94  0.91 1.23  0.72 0.70  0.24
0.73–12.6 0.22–9.44 0.17–3.16
1.46 0.84 0.56
1.72 1.05 0.69
2.13 1.39 0.81
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considered signiﬁcant.Results
Table 2 presents the characteristics of the study subjects in each
data set. The patients in the claims data were, on average,
approximately 10 years younger and included more men than
those in the patient survey. This difference may be explained by
the fact that the Japan Health Insurance Association is a provider
of employees’ health insurance and most of its enrollees are
therefore working men. In both data sets, the encounter intervals
for patients who visited hospitals were much longer than for
those who visited clinics.
In the claims data set, patients treated at hospitals had more
comorbidities than did those treated at clinics. In the patient
survey data, the average encounter interval in FY2011 was longer
than in FY2005 for both patients with hypertension and patients
with diabetes.
The results of multilevel analyses for associations between
patient/area-level characteristics and encounter intervals are
presented in Table 3 (patients with hypertension) and Table 4
(patients with diabetes). The analysis showed signiﬁcant associ-
ations between the number of clinic physicians/1000 people and
physician-patient encounter intervals independent from patient-
level factors in FY2011. An increase of one clinic physician per
1000 people was associated with an average decrease of 6.95 days
in the encounter interval (95% conﬁdence interval [CI] 5.02–8.88
days) in patients with hypertension and 3.66 days (95% CI 0.66–
6.66 days) in patients with diabetes. In contrast, there were no
consistent associations between hospital physician density and
encounter intervals. An increase in hospital physician densityTable 2 – Characteristics of the study subjects in the pat
Patient survey data Hyperten
Clinics
FY2005
Number of patients 34,884
Age (y), mean  SD 69.4  12.8
Sex: male (%) 37.4
Encounter interval (d), mean  SD 18.0  12.6
FY2011
Number of patients 36,420
Age (y), mean  SD 65.5  11.6
Sex: male (%) 39.9
Encounter interval (d), mean  SD 22.6  15.1
Administrative claims data Hyper
Clinics
Number of patients 1,566,986
Age (y), mean  SD 58.5  8.6
Sex: male (%) 57.9
Drug administration period (d), mean  SD 35  14.6
Medical charges, ( 1000 yen), mean  SD 37  34
Number of comorbidities (%)
0 47.2
1 32.3
Z2 20.5
FY, ﬁscal year.was associated with longer encounter intervals in patients with
hypertension but not in patients with diabetes. Patient survey
data in FY2005 showed no association between clinic physician
density and encounter intervals in both patients with hyper-
tension and patients with diabetes, whereas an increase in
hospital physician density showed a signiﬁcant and positive
association with encounter intervals.
In the analysis of the administrative claims data, we also
observed associations between clinic physician density and
encounter intervals in both diseases (Table 5). After controlling
for patients’ demographic characteristics and the number of
comorbidities, an increase of one clinic physician per 1000 people
was associated with an average decrease of 3.38 days in the
encounter interval (95% CI 1.63–5.14) in patients with hyper-
tension and 1.90 days (95% CI 0.27–3.54) in patients with diabetes.
An increase in hospital physician density was associated with an
increase in the encounter intervals of patients with diabetes, but
not patients with hypertension. In all analyses, patients aged 65
years or older (vs. patients younger than 40 years), women, and
the presence of comorbidities were signiﬁcantly associated with
shorter encounter intervals.
In addition, shorter encounter intervals were found to be
associated with higher medical charges (Table 6). Furthermore,
a signiﬁcant and positive association was observed between
physician density and medical charges, and this association
was independent from encounter intervals. These ﬁndings were
consistent in both hospitals and clinics.Discussion
Our analysis of patient survey data and administrative claims
data demonstrated that an increase in clinic physician densityient survey and administrative claims data sets.
sion Diabetes
Hospitals Clinics Hospitals
21,662 7,759 18,568
68.6  13.6 67.2  11.7 64.4  12.8
41.9 51.5 54.6
26.9  19.4 18.9  15.3 30.5  22.1
19,777 8403 17,872
65.6  12.2 62.3  12.0 59.9  13.1
43.1 53.1 57
32.1  23.5 24.1  17.8 34.9  24.9
tension Diabetes
Hospitals Clinics Hospitals
515,752 558,730 257,323
58.4  9.4 58.2  9.3 57.9  9.9
60.5 65.6 65.4
51.1  21.7 33.7  13.1 47.3  19.1
48  48 99  81 105  125
33 – –
33.5 49.4 39.7
33.5 50.6 60.3
Table 3 – Multilevel analysis results of measures of association between patient/area characteristics and
encounter intervals in patients with hypertension using patient survey data.
Variable FY2005 FY2011
Clinics Hospitals Clinics Hospitals
Measures of association
Patient-level variables
Age (40–64 y) 3.14 (2.1–4.18)* 5.05 (3.34–6.76)* 1.88 (2.98 to 0.78)* 2.19 (0.28–4.11)†
Age (Z65 y) 2.06 (3.08 to 1.03)* 1.46 (3.14 to 0.22) 8.31 (9.41 to 7.22)* 6.43 (8.33 to 4.53)*
Male (vs. female) 1.5 (1.23–1.76)* 1.72 (1.22–2.23)* 1.13 (0.82–1.44)* 2.15 (1.51–2.78)*
Area-level variables
Number of clinic
physicians/1000 people
0.93 (2.27 to 0.41) 6.95 (8.88 to 5.02)*
Number of hospital
physicians/1000 people
1.19 (0.32–2.05)* 1.18 (0.01–2.35)†
Measures of variation or clustering
Area-level variance (SE) 11.5 (0.16) 25.53 (0.26) 12.34 (0.18) 47.7 (0.36)
ICC 0.07 0.07 0.06 0.09
Note. Values are coefﬁcient (95% CI) unless otherwise indicated.
CI, conﬁdence interval; FY, ﬁscal year; ICC, intraclass correlation coefﬁcient; SE, standard error.
* P o 0.01.
† P o 0.05.
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ation was independent from patient attributes. These ﬁndings
suggest the presence of SID in Japanese clinics. The intraclass
correlation coefﬁcient in our models ranged from 0.06 to 0.08,
indicating that medical care districts represent a form of social
grouping.
Although previous physician density studies have found
positive relationships between the supply and utilization of
services [5,23], it remains unclear as to whether such associations
reﬂect the existence of SID as a means for physicians to protect
their income, or whether they are indicative of volume-outcome
effects leading to improvements in health services accessibility
and quality. In practice, SID is difﬁcult to identify because
physician service patterns consistent with SID may overlap with
appropriate medical treatment patterns [24]. Moreover, otherTable 4 – Multilevel analysis results of measures of asso
encounter intervals in patients with diabetes using patie
Variable FY2005
Clinics Hosp
Measures of association
Patient-level variables
Age (40–64 y) 1.80 (4.27 to 0.67) 0.97 (0.6
Age (Z65 y) 5.31 (7.75 to 2.86)* 2.43 (3.9
Male (vs. female) 1.25 (0.57–1.92)* 0.27 (0.3
Area-level variables
Number of clinic
physicians/1000 people
0.79 (2.70 to 1.11)
Number of hospital
physicians/1000 people
1.42 (0.54
Measures of variation or clustering
Area-level variance (SE) 14.23 (0.28) 24.95 (0.31)
ICC 0.06 0.05
Note. Values are coefﬁcient (95% CI) unless otherwise indicated.
CI, conﬁdence interval; FY, ﬁscal year; ICC, intraclass correlation coefﬁci
* P o 0.01.
† P o 0.05.factors such as technical advances in health treatments and
changing patient expectations may contribute to increased
health services utilization. Freebairn [25] argues that simple
measurements of changes in health services utilization or prices
in response to regional changes in physician numbers almost
certainly overestimate the magnitude of demand inducement. In
our multilevel analyses, coefﬁcients for clinic physician density
estimated from the claims data were smaller than those esti-
mated from the patient survey data. These differences may have
resulted from the adjustment of comorbidities in the claims data
and intrinsic differences in the measurement of encounter
intervals between the two data sets. Encounter intervals esti-
mated from the drug administration period are more likely to be
indicative of physician-initiated visits, and therefore may repre-
sent a more precise estimate of the magnitude of SID.ciation between patient/area characteristics and
nt survey data.
FY2011
itals Clinics Hospitals
to 2.53) 0.56 (1.26 to 2.37) 2.05 (0.64–3.46)*
7 to 0.88)* 4.74 (6.56 to 2.91)* 1.78 (3.22 to 0.33)†
7 to 0.9) 1.20 (0.45–1.95)* 0.08 (0.81 to 0.65)
3.66 (6.66 to 0.66)†
–2.30)* 0.81 (0.2 to 1.82)
22.60 (0.31) 32.58 (0.36)
0.05 0.05
ent; SE, standard error.
Table 5 – Multilevel analysis results of measures of association between patient/area characteristics and
encounter intervals using administrative claims data.
Variable Hypertension Diabetes
Clinics Hospitals Clinics Hospitals
Measures of association
Patient-level variables
Age (40–64 y) 0.92 (0.47–1.36)* 1.65 (1.04–2.27)* 0.53 (0.11 to 1.17) 4.21 (3.33–5.09)*
Age (Z65 y) 0.34 (0.81 to 0.12) 0.56 (0.08 to 1.21) 0.2 (0.47 to 0.88) 4.82 (3.87–5.76)*
Male (vs. female) 1.35 (1.21–1.49)* 0.96 (0.72–1.2)* 1.08 (0.81–1.34)* 0.84 (0.42–1.26)*
Comorbidity score 0.78 (0.86 to 0.71)* 1.09 (1.2 to 0.98)* 0.52 (0.68 to 0.37)* 1.01 (1.23 to 0.8)*
Area-level variables
Number of clinic
physicians/1000 people
3.38 (5.14 to 1.63)* 1.9 (3.54 to 0.27)†
Number of hospital
physicians/1000 people
0.45 (0.51 to 1.4) 0.92 (0.08–1.77)†
Measures of variation or clustering
Area-level variance (SE) 15.04 (0.15) 40.13 (0.26) 12.1 (0.15) 28.74 (0.24)
ICC 0.08 0.09 0.08 0.08
Note. Values are coefﬁcient (95% CI) unless otherwise indicated.
CI, conﬁdence interval; ICC, intraclass correlation coefﬁcient; SE, standard error.
* P o 0.01.
† P o 0.05.
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association with encounter intervals. Even in cases in which
associations were observed, increases in the number of hospital
physicians were associated with longer encounter intervals. In
Japan, physicians in both hospitals and clinics provide primary
care, but incentives to increase the volume of ambulatory care
differ between the two groups. Most clinic physicians in Japan
are sole proprietors and are reimbursed for the provision of
ambulatory care on a fee-for-service basis. Their remuneration
is therefore dependent on the volume of ambulatory care.Table 6 – Multilevel analysis results of measures of asso
medical charges using administrative claims data.
Variable Hypertension
Clinics Hosp
Measures of association
Patient-level variables
Age (40–64 y) 1.76 (0.4 to 3.92) 2.95 (6.04
Age (Z65 y) 13.68 (11.44–15.93)* 1.76 (1.48
Male (vs. female) 6.25 (6.95 to 5.56)* 7.05 (8.24
Comorbidity score 26.39 (26.02–26.76)* 29.2 (28.65–
Encounter interval 0.62 (0.64 to 0.59)* 0.84 (0.86
Area-level variables
Number of clinic
physicians/1000 people
3.77 (1.59–5.94)*
Number of hospital
physicians/1000 people
3.45 (2.26–
Measures of variation or
clustering
Area-level variance (SE) 13.04 (0.25) 36.05 (0.43)
ICC 0.003 0.003
Note. Values are coefﬁcient (95% CI) unless otherwise indicated.
CI, conﬁdence interval; ICC, intraclass correlation coefﬁcient; SE, standa
* P o 0.01.However, hospital physicians are salaried and increases in the
volume of ambulatory care would not directly increase
their salaries, and instead may serve only to increase their
workload. Moreover, areas with high hospital physician densities
tend to have more highly specialized hospitals. Such hospitals
may prioritize the provision of inpatient care over ambulatory
care, and therefore restrict the volume of ambulatory care
provided.
Medical charges were also signiﬁcantly associated with the
drug administration period in our sample. The observed increaseciation between patient/area characteristics and
Diabetes
itals Clinics Hospitals
to 0.15) 7.82 (3.92–11.72)* 1.77 (3.36 to 6.9)
to 5) 17.21 (13.1–21.32)* 8.54 (3.02–14.05)*
to 5.86)* 8.4 (9.97 to 6.83)* 10.64 (13.02 to 8.25)*
29.74)* 28.88 (27.97–29.8)* 30.93 (29.7–32.17)*
to 0.81)* 0.75 (0.81 to 0.69)* 0.94 (1.01 to 0.88)*
3.54 (0.28 to 7.36)*
4.64)* 2.7 (0.66–4.74)*
22.19 (0.59) 79.54 (0.84)
0.004 0.01
rd error.
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attributable to increases in the volume of laboratory tests and
treatments. In areas with high competition, medical institutions
may invest in expensive medical equipment to attract more
patients and providers may increase the volume of medical
services to maximize their return on investment. Although our
ﬁndings are consistent with the effects of SID, they may be
explained by the concept that physicians tend to be located in
areas where demand for their services is high, or that physicians
increase the provision of health services to cater to patient
preferences [5].
Our study has the following limitations. We did not include
variables that may affect patient demand for health care, such as
socioeconomic status and accessibility/transport costs, into the
analysis because our data lack such information. If these factors
are indeed confounders of physician density, they may jeopard-
ize the estimates of SID effects. Recent studies on regional
variations in rates of medical treatments and spending have
focused on patient characteristics and demand-side factors. A
study from the United States reported that patient health status,
race, and preferences help explain individual ofﬁce visit fre-
quency; yet, these factors are able to explain only a small fraction
of the observed regional differences associated with physician
supply [5,26]. Cutler et al. [27] investigated whether patient
demand-side factors or physician supply-side factors explain
regional variations in Medicare spending and found patient
demand to be relatively unimportant in explaining variations.
Therefore, these variables are not expected to have a substantial
effect on the encounter interval. However, we were unable to
exclude the possible inﬂuence of these factors on differences in
medical charges.
Our analysis of the patient survey data from FY2005 did not
show any association between clinic physician density and
encounter intervals. This lack of association may be due to
restrictions on the drug administration period that existed before
2002: Before April 2002, the drug administration period was
limited to a maximum of 14 days but this limitation was
abolished in 2002 to reduce medical expenses. The abolishment
of these restrictions has possibly inﬂuenced our observed results
in that hospital physicians and clinic physicians in areas of low
competition may use prolonged drug administration periods
because there would be few ﬁnancial incentives to elicit more
frequent patient visits. In contrast, clinic physicians may be
incentivized to maintain shorter drug administration periods to
increase their income.
The likelihood of SID being pervasive also depends on the
health care delivery system. Bickerdyke et al. [5] noted that the
following components of health care organizational and payment
arrangements are particularly conducive to the development of
SID: 1) consumers are free to choose their physician; 2) there are
no contractual or employment relationships between third-party
insurers and physicians; and 3) physicians are paid on a fee-for-
service basis. Under Japan’s free access system, patients with
multiple disease conditions often consult different physicians for
each of their diseases, thereby reducing the efﬁciency of care and
resulting in the administration of redundant diagnostic tests or
medications. In addition, fee-for-service payment systems give
physicians a ﬁnancial incentive to increase the volume (and
possibly the price) of the services they provide, with little reason
to restrict unnecessary care or provide preventive care. This may
induce the overprovision of care and give rise to regional
variations.
Currently, there is no consensus regarding the appropriate
frequency for physician-patient encounters in the treatment of
lifestyle diseases and the encounters are arbitrarily determined
by each physician. The large regional variations in encounter
intervals observed in our study, however, suggest that medicalservices are overused in some areas and underused in others. If
more frequent physician-patient encounters are documented to
improve the control of disease conditions and clinical outcomes,
these encounters may prove to be justiﬁed. If frequent encoun-
ters do not bring any clinical beneﬁts, however, they would be
unnecessary from the perspective of health care quality. Previous
studies that have examined the relationship between encounter
frequency and the control of blood pressure or blood glucose
have shown mixed results: Schectman et al. [28] found that better
metabolic control in patients with diabetes was associated with
greater medication adherence, but reported no association
between metabolic control and encounter frequency. Morrison
et al. [29] conducted a retrospective cohort study to determine the
optimal frequency of provider-patient encounters for patients
with diabetes and reported that biweekly encounters were
associated with the quickest achievement of disease control.
Our results suggest the presence of SID in Japan for patients with
hypertension and diabetes treated by clinic-based physicians.
Future studies should focus on whether frequent physician-
patient encounters are associated with appropriate care and
improved patient outcomes.Acknowledgments
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